Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

DRIM Inhibitors

DRIM inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the DRIM protein, which likely stands for a domain related to intracellular motility or some specific molecular process in cellular dynamics. DRIM, based on its name, may be involved in regulating the movement of intracellular components, contributing to processes such as vesicle transport, cytoskeletal dynamics, or signal transduction. Proteins involved in intracellular motility are crucial for ensuring the proper localization of cellular organelles, vesicles, and proteins, thus playing a key role in maintaining cellular organization and function. By inhibiting DRIM, researchers can explore its specific role in these intracellular processes, potentially shedding light on how it influences transport mechanisms or cytoskeletal rearrangements.

The mechanism of DRIM inhibitors typically involves binding to functional domains of the DRIM protein that are essential for its role in intracellular motility. These inhibitors may block DRIM's interaction with motor proteins, cytoskeletal elements, or other binding partners necessary for its activity. Structurally, DRIM inhibitors are often designed to mimic the protein's natural ligands or interact with key binding sites to prevent proper functioning. This disruption could lead to altered intracellular transport, impaired organelle movement, or changes in cell shape and migration. By studying DRIM inhibitors, researchers can gain valuable insights into the molecular mechanisms of intracellular motility and how specific proteins like DRIM contribute to maintaining the spatial organization and transport dynamics of various cellular components. This knowledge enhances understanding of the broader regulatory networks involved in intracellular movement and cellular architecture.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Known to inhibit PI3K, a crucial kinase in several signaling pathways. By inhibiting PI3K, downstream signaling events can be affected.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Another PI3K inhibitor which can disrupt downstream signaling.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

An inhibitor of MEK, part of the MAPK/ERK pathway. Its inhibition can disrupt several cellular processes.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Targets p38 MAP kinase, potentially affecting signaling pathways where p38 is involved.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that can disrupt AP-1 mediated transcription among other processes.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Broad-spectrum kinase inhibitor which can affect multiple pathways.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

Src family kinase inhibitor, potentially affecting various cellular signaling pathways.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

NF-κB pathway inhibitor. This can affect various cellular processes regulated by NF-κB.

IKK-2 Inhibitor IV

507475-17-4sc-203083
500 µg
$133.00
12
(1)

Specifically inhibits IKK-2, thereby affecting the NF-κB pathway.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

Intracellular calcium chelator, affecting calcium signaling pathways.